Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-028417
Filing Date
2025-12-18
Accepted
2025-12-18 21:56:14
Documents
1
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 13133
  Complete submission text file 0001493152-25-028417.txt   14801
Mailing Address 401 EAST JACKSON STREET SUITE 3300 TAMPA FL 33602
Business Address 401 EAST JACKSON STREET SUITE 3300 TAMPA FL 33602 (929) 274-7510
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address
Gaslightwala Abizer (Reporting) CIK: 0002049375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36288 | Film No.: 251584825